Cargando…
Use of National Database of Health Insurance Claims and Specific Health Checkups for examining practical utilization and safety signal of a drug to support regulatory assessment on postmarketing drug safety in Japan
The Pharmaceuticals and Medical Devices Agency (PMDA) has conducted many pharmacoepidemiological studies for postmarketing drug safety assessments based on real-world data from medical information databases. One of these databases is the National Database of Health Insurance Claims and Specific Heal...
Autores principales: | Shida, Haruka, Kajiyama, Kazuhiro, Sawada, Sono, Ishiguro, Chieko, Kubo, Mikiko, Kimura, Ryota, Hirano, Mai, Komiyama, Noriyuki, Iguchi, Toyotaka, Oniyama, Yukio, Uyama, Yoshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995365/ https://www.ncbi.nlm.nih.gov/pubmed/36910503 http://dx.doi.org/10.3389/fmed.2023.1096992 |
Ejemplares similares
-
Cardiovascular risk of urate‐lowering drugs: A study using the National Database of Health Insurance Claims and Specific Health Checkups of Japan
por: Sawada, Sono, et al.
Publicado: (2022) -
Effect of Hepatitis C Drugs on Blood Coagulability in Patients on Warfarin Using the Medical Information Database Network (MID-NET(®)) in Japan
por: Sawada, Sono, et al.
Publicado: (2021) -
Nested Case‐Control Study Utilizing MID‐NET® on Thrombocytopenia Associated With Pegfilgrastim in Patients Treated With Antineoplastic Agents
por: Kajiyama, Kazuhiro, et al.
Publicado: (2021) -
Assessing the Risk of Decrease in Kidney Function in Patients Prescribed Direct-Acting Antivirals for Hepatitis C Utilizing the MID-NET(®) Medical Information Database Network in Japan
por: Hasegawa, Tomoaki, et al.
Publicado: (2022) -
An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance
por: Misu, Takashi, et al.
Publicado: (2018)